Search Results - Shukla, Umesh
- Showing 1 - 5 results of 5
-
1
-
2
-
3
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection by Zoulim, Fabien, Moreno, Christophe, Lee, Samuel S., Buggisch, Peter, Horban, Andrzej, Lawitz, Eric, Corbett, Chris, Lenz, Oliver, Fevery, Bart, Verbinnen, Thierry, Shukla, Umesh, Jessner, Wolfgang
Published 2018Text -
4
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study by Shukla, Umesh, Ujjaliya, Nitin, Gupta, Pankaj, Khare, Vivek, Yadav, Babita, Rai, Amit Kumar, Amin, Hetalben, Rana, Rakesh, Tripathi, Arunabh, Khanduri, Shruti, Sharma, Bhagwan Sahay, Chandrasekhararao, Bhogavalli, Srikanth, Narayanam, Dhiman, Kartar Singh
Published 2020Text -
5
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study by Gane, Edward J., DeJesus, Edwin, Janczewska, Ewa, George, Jacob, Diago, Moises, Da Silva, Mariliza Hendrique, Reesink, Henk, Nikitin, Igor, Hinrichsen, Holger, Bourgeois, Stefan, Ferenci, Peter, Shukla, Umesh, Kalmeijer, Ronald, Lenz, Oliver, Fevery, Bart, Corbett, Chris, Beumont, Maria, Jessner, Wolfgang
Published 2017Text